This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Family history of other specific disorders
Z21_FAMILY_HISTORY_OTH_SPECIFIC_DISORD
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
474 |
4. Check minimum number of eventsNone |
474 |
5. Include endpointsNone |
474 |
6. Filter based on genotype QC (FinnGen only) |
474 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[8-9]
Similar endpoints
↥List of similar endpoints to
Family history of other specific disorders
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 474 | 355 | 119 |
| Unadjusted period prevalence (%) | 0.10 | 0.12 | 0.05 |
| Median age at first event (years) | 40.13 | 37.87 | 46.87 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 405
- Matched controls
- 4049
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z83.4
ICD-10 Finland
Family history of other endocrine, nutritional and metabolic diseases
+∞
215.4
187
*
Z31.5
ICD-10 Finland
Genetic counselling
34.7
129.9
173
85
Z83.2
ICD-10 Finland
Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
+∞
93.4
86
*
Z83.5
ICD-10 Finland
Family history of eye and ear disorders
295.7
74.0
73
*
Z83.3
ICD-10 Finland
Family history of diabetes mellitus
+∞
21.0
20
*
Z83.7
ICD-10 Finland
Family history of diseases of the digestive system
+∞
17.8
17
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
12.7
13.8
24
20
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
123.3
11.5
12
*
O35.2
ICD-10 Finland
Maternal care for (suspected) hereditary disease in fetus
61.6
10.7
12
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
+∞
10.5
10
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
+∞
10.5
10
*
Z83.6
ICD-10 Finland
Family history of diseases of the respiratory system
+∞
10.5
10
*
Z83.1
ICD-10 Finland
Family history of other infectious and parasitic diseases
+∞
10.5
10
*
Z82.7
ICD-10 Finland
Family history of congenital malformations, deformations and chromosomal abnormalities
+∞
9.4
9
*
F38
ICPC
Eye, Other laboratory test NEC
24.7
9.0
12
5
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
8.2
9.0
19
24
WX720
NOMESCO Finland
Own respiration
5.6
8.3
23
43
H40.0
ICD-10 Finland
Glaucoma suspect
3.6
7.5
32
93
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
9.0
7.1
14
16
SPAT1263
SPAT
Sampling
1.8
6.9
179
1255
I49.5
ICD-10 Finland
Sick sinus syndrome
10.3
6.6
12
12
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.3
6.4
58
273
E83.1
ICD-10 Finland
Disorders of iron metabolism
18.4
6.3
9
5
D66
ICD-10 Finland
Hereditary factor VIII deficiency
+∞
6.3
6
*
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
+∞
6.3
6
*
Z84.8
ICD-10 Finland
Family history of other specified conditions
+∞
6.3
6
*
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
+∞
6.3
6
*
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
+∞
6.3
6
*
WX725
NOMESCO Finland
Noninvasive ventilation
3.9
6.1
23
61
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
35
124
2.97
7.71
11.2
7.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
97
551
1.96
7.39
4.1
2.8
ng/l
169.2
304.2
0.54
67
338
(3032080) INR in Blood by Coagulation assay
161
1091
1.72
6.85
7.7
5.6
inr
1.1
1.1
0.03
42
337
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
42
4.16
6.40
2.8
1.4
nmol/l
—
—
—
0
0
(3019060) Gas panel - Arterial blood
36
150
2.52
5.86
4.1
4.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
79
457
1.87
5.63
2.8
2.0
umol/l
14.6
14.5
0.02
68
417
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
17
48
3.64
5.37
3.4
1.4
nmol/l
0.4
0.5
0.23
17
43
(3037467) Urinalysis macro (dipstick) panel - Urine
319
2666
1.60
5.35
3.9
3.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
250
1980
1.56
5.28
4.8
3.8
mmol/l
6.5
6.4
0.34
215
1769
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
128
874
1.64
5.07
2.3
2.2
mg/l
2.3
2.8
3.11
112
754
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
39
181
2.26
5.03
1.6
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
243
1931
1.53
4.93
3.6
2.8
ug/l
74.0
73.5
0.03
231
1799
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
126
873
1.60
4.66
1.7
2.0
u/l
178.6
251.0
0.39
119
830
(3018677) aPTT in Platelet poor plasma by Coagulation assay
71
423
1.80
4.59
2.0
2.4
s
28.8
29.8
1.10
66
412
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
45
231
2.05
4.53
1.9
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
144
1037
1.56
4.50
2.6
2.2
u/l
54.6
54.1
0.07
138
966
(42870588) Differential panel, method unspecified - Blood
160
1186
1.53
4.36
5.3
5.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
65
383
1.81
4.36
3.3
3.7
%
32.5
32.0
0.16
46
254
(3031040) Bacteria [#/volume] in Urine by Automated count
296
2500
1.49
4.18
4.1
3.8
e6/l
5559.2
235.4
—
6
28
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
194
1508
1.48
4.17
2.6
2.3
nmol/l
74.2
74.6
0.06
185
1368
(3004789) Transferrin [Mass/volume] in Serum or Plasma
68
413
1.75
4.12
2.9
1.9
g/l
2.5
2.4
0.41
61
375
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
10
8.11
4.07
1.4
4.7
ug/l
1.1
2.0
—
8
10
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
198
1552
1.47
4.05
7.9
5.3
mmol/l
1.2
1.2
0.09
168
1322
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
241
0.28
4.00
1.1
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
63
379
1.76
3.95
2.8
2.0
%
25.9
24.3
0.35
41
334
(3035637) Corticotropin [Mass/volume] in Plasma
14
43
3.32
3.93
1.4
1.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
65
2.84
3.89
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
236
0.29
3.85
1.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
237
0.28
3.85
1.1
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
18
68
2.71
3.60
2.2
1.5
mmol/l
6.3
6.8
0.43
11
44
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
46
3.11
3.55
3.4
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
89
0.00
3.53
0.0
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
58
906
0.59
3.52
3.1
3.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
62
945
0.60
3.41
5.8
6.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
23
102
2.32
3.34
2.5
2.9
g/l
1.2
1.3
0.22
23
92
(3023103) Potassium [Moles/volume] in Serum or Plasma
411
3791
1.63
3.29
13.2
10.4
mmol/l
3.9
3.9
0.48
393
3660
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
215
1763
1.40
3.24
4.8
3.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
314
2750
1.42
3.20
4.0
3.7
mm/h
9.9
9.6
0.18
297
2556
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
15
5.40
3.20
5.3
3.3
nmol/l
65.8
82.8
—
8
15
(40761511) CBC panel - Blood by Automated count
443
4177
1.93
3.19
13.8
9.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
17
67
2.59
3.16
2.3
2.0
mmol/l
8.5
7.2
1.53
11
40
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
38
210
1.88
3.15
2.0
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
409
3778
1.60
3.13
13.1
10.4
mmol/l
139.6
139.6
0.13
392
3659
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
210
1731
1.38
3.00
5.9
5.0
umol/l
11.6
10.6
0.43
204
1630
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
5
10.09
2.98
2.8
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
22
4.15
2.89
1.2
1.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
167
1335
1.39
2.84
5.9
3.9
g/l
36.4
36.7
0.35
157
1246
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
121
920
1.42
2.74
1.8
1.6
mmol/l
1.3
1.3
0.06
110
804
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
174
1412
1.37
2.67
6.5
4.8
mmol/l
1.2
1.2
0.03
159
1279
(3026493) Urate [Moles/volume] in Serum or Plasma
106
793
1.43
2.61
2.5
2.3
umol/l
3916.9
7051.3
0.36
95
708
(3003396) Base excess in Arterial blood by calculation
44
270
1.69
2.61
9.9
6.8
mmol/l
1.8
0.9
1.00
30
200
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
312
0.43
2.59
1.2
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
36
210
1.77
2.55
2.3
2.9
e9/l
66.1
72.6
0.83
31
154
(4010399)
39
234
1.73
2.51
1.2
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
411
3843
1.52
2.50
14.2
11.1
%
39.4
40.1
0.73
290
3120
(36660697) Celiac disease serology panel - Serum
58
387
1.57
2.48
1.1
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
12
5.05
2.41
3.0
3.8
u/l
199.7
194.3
—
6
12
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
323
3524
0.74
2.39
9.1
8.9
ml/min/173m2
92.6
90.6
0.92
265
2773
(21494814) CD8 cells/100 lymphocytes in Specimen
5
8
6.30
2.37
1.2
2.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
392
3642
1.44
2.36
4.9
4.6
mu/l
1.7
2.1
0.62
365
3399
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
33
538
0.58
2.35
2.2
2.3
e6/l
0.8
1.0
0.27
21
291
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
418
3937
1.52
2.30
11.7
10.0
mg/l
16.9
20.7
2.11
336
2951
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
50
329
1.58
2.28
2.1
2.2
u/l
22982.5
3998.1
1.53
22
142
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
13
4.66
2.28
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
48
313
1.59
2.27
2.2
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
74
531
1.47
2.27
1.8
2.0
—
—
—
0
0
(3019225) pH of Specimen
43
273
1.63
2.27
2.9
3.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
86
2.14
2.25
1.1
1.2
—
1.5
—
0
7
(3012516) Albumin [Mass/volume] in Urine
102
780
1.39
2.21
3.8
3.2
mg/l
777.3
325.8
0.26
63
499
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
24
3.37
2.19
1.8
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
167
0.35
2.18
3.7
2.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
48
318
1.57
2.14
2.0
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
92
701
1.39
2.04
1.5
1.5
nmol/l
23.2
21.1
0.60
78
602
(3020682) Albumin/Creatinine [Ratio] in Urine
106
827
1.36
2.03
4.4
3.8
mg/mmol
9.3
10.2
0.06
62
517
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
90
2.04
2.03
1.6
1.3
ug/g
214.4
314.8
—
9
51
(3030467) Casts [#/volume] in Urine by Automated count
69
920
0.71
1.92
3.0
2.5
e6/l
0.2
0.3
0.20
49
662
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
26
151
1.76
1.91
1.0
1.1
—
6.1
—
0
27
(3013139) Helicobacter pylori Ag [Presence] in Stool
39
257
1.56
1.80
1.2
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
11
47
2.37
1.79
1.3
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
81
619
1.37
1.77
1.5
1.5
pmol/l
412.5
39286138.8
1.08
68
532
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
16
293
0.53
1.74
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
16
293
0.53
1.74
1.2
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
382
3585
1.34
1.73
3.9
3.6
mmol/l
5.7
5.7
0.03
354
3308
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
16
292
0.53
1.73
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
292
0.53
1.73
1.2
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
13
3.87
1.72
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
13
252
0.50
1.69
2.1
3.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
63
465
1.41
1.69
2.2
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
34
506
0.65
1.68
2.3
2.4
e6/l
1.5
3.3
1.86
21
264
(36304419) Bacteria [Presence] in Urine
71
922
0.73
1.67
2.8
2.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
299
2725
1.26
1.67
7.4
6.0
u/l
74.7
75.9
0.24
291
2538
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
19
3.18
1.66
1.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
20
113
1.80
1.63
1.1
1.2
—
3.1
—
0
13
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
296
2700
1.26
1.62
3.3
2.7
u/l
35.9
39.5
0.54
282
2562
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
14
3.60
1.62
1.0
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
104
1270
0.77
1.59
3.0
3.1
e6/l
76.8
54.6
0.20
68
817
(3017446) Testosterone [Moles/volume] in Serum or Plasma
31
200
1.59
1.58
2.0
1.6
nmol/l
12.0
13.0
0.21
25
178
(3041096) Erythrocytes [Presence] in Urine by Automated
130
1081
1.28
1.57
2.7
2.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
21
122
1.75
1.57
1.2
1.3
—
1.1
—
0
6
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
154
1.66
1.53
2.7
2.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
45
0.00
1.50
0.0
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
459
4475
1.81
1.48
18.3
15.1
e9/l
259.4
259.7
0.04
449
4373
(3019309) Folate [Moles/volume] in Red Blood Cells
64
487
1.36
1.45
1.9
1.6
nmol/l
1174.9
1200.9
0.09
47
366
(3024731) MCV [Entitic volume]
459
4477
1.80
1.44
18.2
15.0
fl
89.5
90.0
1.58
452
4428
(3026361) Erythrocytes [#/volume] in Blood
459
4478
1.79
1.43
18.3
15.0
e12/l
4.5
4.5
0.03
449
4366
(3035941) MCH [Entitic mass]
459
4478
1.79
1.43
18.2
15.0
pg
30.0
30.1
0.54
452
4428
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
179
0.49
1.42
2.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
90
723
1.30
1.42
1.3
1.3
iu/ml
14.8
34.6
2.88
29
214
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
74
1.92
1.40
2.2
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
74
1.92
1.40
5.4
3.9
%
53.7
57.5
0.39
14
74
(3010813) Leukocytes [#/volume] in Blood
459
4481
1.77
1.37
18.3
15.1
e9/l
6.9
6.7
0.57
448
4367
(3000963) Hemoglobin [Mass/volume] in Blood
459
4481
1.77
1.37
18.4
15.1
g/l
134.8
135.4
0.44
452
4431
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
149
1278
1.24
1.37
3.7
2.9
u/l
27.8
29.9
0.68
141
1223
(3009508) Creatinine [Moles/volume] in Urine
114
950
1.26
1.35
3.6
2.9
mmol/l
7.5
8.1
0.68
102
806
(3044889) 12 lead EKG panel
260
2366
1.22
1.34
3.1
2.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
346
3245
1.25
1.32
5.6
4.5
mmol/mol
38.4
38.1
0.27
323
3048
(3024354) Oxygen [Partial pressure] in Venous blood
13
231
0.55
1.32
4.0
3.4
kpa
4.5
4.7
0.26
13
225
(3021589) Normoblasts [#/volume] in Blood
146
1680
0.81
1.31
8.2
7.8
e9/l
0.0
0.0
1.54
124
1351
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
76
1.87
1.31
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
24
2.52
1.30
1.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
341
3196
1.24
1.30
3.4
3.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
145
1250
1.23
1.26
2.0
1.8
pmol/l
99.4
97.4
0.15
67
640
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
25
2.42
1.24
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
141
0.49
1.22
1.1
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
37
2.18
1.22
1.1
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
19
2.65
1.22
1.0
1.2
miu/ml
1270.8
1569.1
—
5
19
(3018418) pH of Serum or Plasma
111
934
1.25
1.21
4.4
3.3
ph
7.4
7.4
0.51
23
159
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
47
615
0.74
1.18
1.7
2.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
83
1005
0.79
1.17
2.8
2.6
e6/l
13.3
43.6
2.24
61
746
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
72
1.83
1.16
5.4
3.6
e9/l
3.5
4.3
0.81
13
72
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
27
183
1.50
1.16
1.5
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
20
2.52
1.15
6.2
8.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
30
2.35
1.12
1.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
51
1.98
1.12
2.3
2.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
51
392
1.34
1.11
1.5
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
137
0.50
1.11
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
166
0.53
1.10
1.1
1.7
—
—
—
0
0
(4062490)
8
41
1.97
1.09
1.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
50
388
1.32
1.03
1.8
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
44
567
0.75
1.01
2.2
2.5
mmol/l
2.4
2.4
0.47
39
490
(3022096) Basophils/100 leukocytes in Blood
188
1694
1.18
1.00
5.3
5.7
%
0.8
0.7
0.81
179
1578
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
35
2.01
1.00
1.1
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
7
132
0.52
1.00
1.4
3.3
%
0.7
0.6
—
7
127
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
135
0.51
0.99
1.1
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
425
4120
1.31
0.99
9.6
8.2
u/l
26.6
25.2
0.80
414
3984
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
36
1.96
0.97
1.1
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
36
1.96
0.97
1.7
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
368
3515
1.21
0.96
3.5
3.2
mmol/l
1.2
1.2
1.04
346
3279
(3000991) Gas panel - Venous blood
15
233
0.63
0.96
21.4
6.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
86
723
1.23
0.95
1.3
1.3
u/ml
1.9
8.8
2.87
22
283
(3006504) Eosinophils/100 leukocytes in Blood
194
1759
1.17
0.95
5.4
5.6
%
2.8
2.8
0.01
186
1646
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
330
3124
1.19
0.94
4.3
4.0
pmol/l
14.5
14.4
0.18
303
2883
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
37
1.91
0.94
1.1
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
37
1.91
0.94
1.1
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
195
1772
1.17
0.92
5.8
5.9
%
8.1
8.1
0.02
188
1663
(3005570) Glucose [Moles/volume] in Urine
6
28
2.16
0.92
1.7
2.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
96
821
1.21
0.90
2.3
1.8
mg/l
0.9
0.9
0.17
71
599
(3020891) Body temperature
5
101
0.49
0.90
2.8
4.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
9
153
0.58
0.90
29.9
8.5
%
95.2
94.1
—
9
153
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
128
0.54
0.89
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
42
1.92
0.89
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
42
1.92
0.89
1.3
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
85
995
0.82
0.88
3.2
3.3
estimate
0.1
0.0
0.43
35
351
(3021788) Differential panel - Synovial fluid
8
43
1.87
0.87
2.0
1.7
—
—
—
0
0
(44790047)
6
30
2.01
0.87
3.2
1.4
—
—
—
0
0
(44790048)
6
30
2.01
0.87
3.2
1.4
—
—
—
0
0
(44806118)
6
30
2.01
0.87
3.2
1.4
—
—
—
0
0
(44790049)
6
30
2.01
0.87
3.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
21
145
1.47
0.86
1.4
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
202
1849
1.16
0.86
5.4
5.6
%
30.7
29.6
0.76
194
1736
(3026389) Candida sp identified in Specimen by Organism specific culture
8
44
1.83
0.86
1.8
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
42
328
1.31
0.85
3.8
3.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
199
1822
1.16
0.84
4.7
5.5
%
55.1
56.1
0.73
191
1716
(3026008) Bacteria identified in Urine by Culture
118
1037
1.18
0.83
2.7
2.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
53
430
1.26
0.81
2.2
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
103
1173
0.84
0.79
2.6
2.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
24
0.00
0.79
0.0
2.7
—
21.7
—
0
16
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
16
233
0.68
0.78
3.2
2.4
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.3
—
8.3
—
0
21
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
116
1025
1.17
0.77
1.9
1.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
6
34
1.77
0.76
1.5
1.2
mosm/kgh2o
267.7
285.2
—
6
25
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
17.8
—
1916.6
—
0
28
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
12.5
—
928.6
—
0
28
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.1
—
102.7
—
0
28
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
17
242
0.69
0.74
1.7
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
38
1.85
0.74
2.6
1.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
109
0.54
0.73
1.2
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
25
2.01
0.73
1.6
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
39
1.81
0.72
1.0
1.2
—
—
—
0
0
(4268621)
9
56
1.62
0.72
2.4
2.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
34
265
1.30
0.72
2.7
2.7
g/l
0.2
0.2
0.19
34
248
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
61
1.65
0.69
2.6
1.4
—
—
—
0
0
(4306422)
11
69
1.61
0.69
1.4
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
69
1.61
0.69
1.5
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
59
1.54
0.68
2.8
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
2.8
1.4
g/l
0.8
0.9
—
5
27
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
27
1.86
0.68
11.6
2.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
2.2
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
382
3696
1.17
0.68
4.0
3.6
mmol/l
4.7
4.7
0.02
359
3474
(3034274) Bile acid [Moles/volume] in Serum --fasting
16
111
1.46
0.66
2.4
2.1
umol/l
3.1
5.0
1.89
11
80
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
39
478
0.80
0.64
1.5
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
79
1.53
0.63
1.3
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
30
235
1.30
0.63
3.4
4.1
%
1.7
0.3
—
6
44
(3021440) Promyelocytes/100 leukocytes in Blood
31
244
1.29
0.63
4.0
4.3
%
0.1
0.2
—
8
58
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
49
1.64
0.62
1.1
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
42
345
1.24
0.61
1.6
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
20
0.00
0.60
0.0
2.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
20
0.00
0.60
0.0
2.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
106
950
1.15
0.59
1.6
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
298
0.76
0.59
1.3
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
20
264
0.75
0.59
1.8
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
379
3679
1.15
0.58
4.1
3.5
mmol/l
1.5
1.5
0.45
355
3445
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
36
1.68
0.57
1.2
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
29
230
1.28
0.57
4.2
4.5
%
0.8
0.0
—
8
47
(3028300) Cannabinoids [Presence] in Urine
22
284
0.76
0.56
1.8
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
15
107
1.42
0.56
1.7
3.5
g/l
0.4
0.2
—
5
48
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
90
1.46
0.56
1.4
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
22
283
0.77
0.55
1.8
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
22
283
0.77
0.55
1.8
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
23
294
0.77
0.55
15.7
14.4
inr
1.1
1.2
—
9
42
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
60
1.51
0.54
3.8
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
193
0.72
0.54
2.8
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
38
1.59
0.54
1.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
281
0.77
0.52
1.8
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
96
0.62
0.52
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
96
0.62
0.52
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
97
0.61
0.52
6.5
2.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
58
504
1.17
0.50
4.7
4.5
ug/l
2.6
1.9
0.36
52
454
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
384
3744
1.14
0.48
4.5
3.9
mmol/l
2.8
2.8
0.24
360
3495
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
222
0.76
0.48
1.9
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
47
1.50
0.47
1.3
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
47
1.50
0.47
10.6
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
218
1.25
0.47
2.3
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
13
94
1.39
0.46
1.4
2.4
mg/l
8.5
11.0
0.66
13
87
(4094501)
5
81
0.61
0.46
1.6
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
86
951
0.88
0.46
2.2
2.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
164
0.72
0.46
1.2
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
60
679
0.87
0.45
2.7
2.2
e6/l
4.7
8.3
1.71
49
584
(3048689) Calprotectin [Mass/mass] in Stool
66
585
1.15
0.45
2.2
2.7
ug/g
103.1
110.0
0.09
58
459
(40768797) Stomach Pathology biopsy report
54
472
1.16
0.44
1.2
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
127
0.70
0.44
1.4
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.4
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
31
259
1.21
0.41
3.1
2.5
e9/l
3.7
4.1
0.61
25
227
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
30
250
1.21
0.41
5.3
3.8
ug/l
1.7
23.6
0.69
22
203
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
11
79
1.40
0.41
1.5
1.1
u/ml
126.1
110.1
—
5
13
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
46
400
1.17
0.41
3.7
2.1
umol/l
4.5
6.9
1.52
37
340
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
149
0.73
0.40
1.6
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
31
260
1.21
0.40
4.1
4.2
%
1.3
0.7
—
8
67
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
119
1103
1.11
0.40
1.4
1.3
u/ml
2.9
1.9
0.27
28
285
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
119
1104
1.10
0.39
2.4
2.8
ng/l
26.9
30.1
0.08
47
588
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
124
1.30
0.39
1.7
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
80
1.38
0.38
1.3
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
66
1.37
0.38
1.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
36
1.39
0.38
1.8
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.37
1.4
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
79
0.63
0.35
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
2.0
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
44
1.37
0.34
1.5
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
47
416
1.14
0.34
4.1
3.8
%
25.5
21.9
0.43
14
183
(3019832) Treponema pallidum Ab [Presence] in Serum
92
849
1.10
0.34
1.8
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
45
1.34
0.34
1.0
5.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
86
0.69
0.33
1.0
1.1
—
12.9
—
0
5
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
25
295
0.84
0.33
1.4
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
57
631
0.89
0.33
2.7
2.3
mosm/kgh2o
531.1
577.9
0.67
45
530
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
47
1.28
0.32
6.0
3.1
u/ml
17.3
15.3
—
6
47
(3032773) Endomysium IgG Ab [Titer] in Serum
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
196
0.81
0.30
1.3
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
24
203
1.19
0.30
1.7
1.5
mg/l
5.1
2.8
0.63
15
133
(3013115) Eosinophils [#/volume] in Blood
204
1962
1.07
0.28
4.9
5.9
e9/l
0.2
0.2
0.12
183
1746
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
194
0.82
0.28
1.3
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
63
1.27
0.28
1.4
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
8
64
1.25
0.27
1.3
4.5
—
3.6
—
0
6
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
8
65
1.23
0.27
1.3
4.6
mg/l
18.9
27.3
—
8
52
(3034860) Kappa light chains.free [Mass/volume] in Serum
8
65
1.23
0.27
1.3
4.6
mg/l
20.7
42.0
—
8
51
(3008898) HLA-B27 [Presence]
18
214
0.83
0.26
1.0
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
70
647
1.10
0.26
2.6
2.6
ng/l
767.9
807.4
0.05
59
517
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
71
0.70
0.26
1.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
57
522
1.10
0.26
1.5
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
73
1.24
0.25
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
10
78
1.29
0.24
1.0
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
30
265
1.14
0.24
3.0
2.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
107
1129
0.93
0.24
1.7
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
66
613
1.09
0.23
1.5
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
91
0.77
0.22
1.0
1.7
e6/l
92.9
278.5
—
7
74
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
116
1.21
0.22
2.1
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
41
1.22
0.22
2.6
1.7
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
152.9
—
0
10
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
101
0.79
0.21
1.3
1.9
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
12
0.00
0.21
0.0
1.4
—
101.3
—
0
12
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
7.9
—
0
12
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
43
1.16
0.21
2.2
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
137
1314
1.06
0.21
1.6
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000492) Spirometry study
33
365
0.90
0.20
1.5
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
2.5
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
186
1919
0.95
0.20
4.5
4.3
estimate
0.0
0.0
0.50
35
360
(3009261) Glucose [Presence] in Urine by Test strip
188
1937
0.95
0.19
3.1
3.1
estimate
0.0
0.0
0.50
37
347
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
128
1.18
0.18
1.6
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
89
846
1.06
0.18
2.9
3.2
kg/l
1.0
1.0
0.02
19
120
(1761868) Lipid panel - Serum or Plasma
148
1429
1.05
0.18
2.4
2.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
152
1469
1.05
0.18
3.2
3.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
61
1.15
0.17
1.0
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
13
110
1.19
0.17
1.8
1.7
—
154.3
—
0
7
(1002224) Polysomnography panel
21
186
1.14
0.17
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
66
0.76
0.17
3.2
2.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
68
0.73
0.17
1.6
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
92
1.20
0.16
1.3
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
73
1.10
0.15
1.3
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
77
0.78
0.15
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
82
858
0.95
0.15
2.1
2.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
186
1906
0.96
0.14
3.0
3.1
estimate
0.0
0.0
0.00
36
351
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
112
1.17
0.14
1.9
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
42
392
1.08
0.14
1.4
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
141
1.14
0.14
1.1
1.4
g/l
1.1
1.2
0.80
16
134
(3049717) Cytology report of Urine Cyto stain
10
84
1.19
0.14
2.0
2.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
26
238
1.10
0.13
2.2
2.4
u/ml
18.3
29.7
1.05
21
227
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
200
1.10
0.12
1.9
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
11
127
0.86
0.12
2.5
2.0
iu/l
3.0
5.5
—
5
51
(3012544) pH of Venous blood
25
272
0.91
0.12
3.6
3.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
85
1.18
0.12
1.7
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
35
374
0.93
0.12
1.2
1.3
iu/ml
140.3
156.7
0.08
15
148
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
153
1.12
0.11
1.5
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
86
1.17
0.11
1.1
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
134
1.12
0.11
1.4
2.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
231
1.09
0.11
1.4
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
220
2165
1.03
0.10
6.0
8.1
e9/l
3.8
4.0
1.07
192
1875
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
45
1.11
0.10
1.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
360
0.94
0.09
3.2
5.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
48
1.04
0.09
1.6
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
351
3481
1.03
0.09
15.0
12.3
%
13.3
13.4
1.55
346
3424
(40768793) Breast Pathology biopsy report
11
97
1.14
0.09
1.1
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
62
0.80
0.08
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
62
0.80
0.08
1.4
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
93
954
0.97
0.08
1.4
1.4
g/l
2.1
2.1
0.22
63
594
(21494755) Public health laboratory ask at order entry panel
50
518
0.96
0.07
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
28
295
0.95
0.06
1.0
1.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
199
1968
1.02
0.05
4.9
5.6
e9/l
1.9
2.0
0.37
180
1761
(3001604) Monocytes [#/volume] in Blood
191
1889
1.02
0.05
4.9
5.7
e9/l
0.5
0.5
0.04
173
1645
(3000494) Fungus identified in Specimen by Culture
40
414
0.96
0.05
1.6
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
31
323
0.96
0.05
1.5
1.3
—
—
—
0
0
(4035726)
26
248
1.05
0.05
1.5
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
179
1.06
0.05
2.2
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
126
1242
1.02
0.05
2.0
2.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
63
645
0.97
0.04
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
43
443
0.97
0.04
1.9
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
191
1893
1.02
0.04
4.9
5.7
e9/l
0.0
0.0
0.16
173
1652
(3015171) Extractable nuclear Ab [Units/volume] in Serum
17
161
1.06
0.03
1.2
1.2
—
0.9
—
0
14
(3004588) Protein electrophoresis panel - Serum or Plasma
18
171
1.05
0.03
1.2
2.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
29
300
0.96
0.03
2.8
2.3
—
19.2
—
0
17
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
19
181
1.05
0.03
4.1
3.0
mmol/l
0.7
1.6
0.60
13
128
(3023368) Bacteria identified in Blood by Culture
71
722
0.98
0.03
4.0
3.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
241
1.04
0.02
2.2
2.1
ml/min/173m2
80.9
76.7
0.23
13
80
(3015377) Calcium [Moles/volume] in Serum or Plasma
112
1110
1.01
0.02
3.1
2.6
mmol/l
2.4
2.4
0.20
96
978
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
31
318
0.97
0.02
2.4
2.6
ug/l
0.8
0.7
0.23
17
203
(40760892) CBC W Ordered Manual Differential panel - Blood
91
918
0.99
0.01
3.9
4.1
—
—
—
0
0
(3002256) Pathology report gross observation
41
417
0.98
0.01
1.2
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
10
94
1.07
0.01
8.1
4.1
mg/l
1.3
1.3
—
10
84
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
14
136
1.03
0.00
1.1
1.5
g/l
0.2
0.2
0.33
14
129
(3037522) Nuclear Ab [Titer] in Serum
56
565
0.99
0.00
1.6
1.4
titre
616.0
430.2
0.23
15
110
(3023511) Choriogonadotropin [Units/volume] in Urine
19
188
1.01
0.00
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
21
208
1.01
0.00
1.3
1.4
miu/ml
263.8
289.3
0.10
11
107
(3022313) Gas panel - Capillary blood
14
139
1.01
0.00
2.6
3.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
115
1149
1.00
0.00
2.4
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
150
1505
1.00
0.00
2.1
1.9
—
—
—
0
0
(3013512) EKG study
82
825
0.99
0.00
3.9
2.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
85
854
0.99
0.00
2.5
1.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
8
89
0.90
0.00
1.0
1.5
mmol/l
3.9
3.6
—
8
82
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
52
0.96
0.00
1.0
1.4
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
1.2
—
0
5
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
1.2
—
0
5
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
7
0.00
0.00
0.0
5.9
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
35.8
—
0
5
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.1
—
18.3
—
0
9
(1761482) Bacteria [#/volume] in Urine by Culture
7
77
0.91
0.00
2.6
3.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_FAMILY_HISTORY_OTH_SPECIFIC_DISORD – Family history of other specific disorders
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).